Development

Anti-aging gene therapy enters clinical testing

development2026-04-09

Claim

Life Biosciences raised $80 million to begin clinical testing of its anti-aging gene therapy, while GLP-1 drugs are projected to add $13 billion in apparel sales as Americans shrink out of their wardrobes.

Reported metric: $80M / $13B

Reporting date: 2026-04-09 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to April 9, 2026 (theinnermostloop.substack.com)

Knowledge graphopen in browser →

Reported in

Welcome to April 9, 2026

Actor

Life Biosciences

Evidence for

Biology engineered past the constraints of life

Supersedes

A compound in python blood suppresses appetite without nausea

Referenced by

Cite or correct this record

Citation formatCitation text

Anti-aging gene therapy enters clinical testing
Innermost Loop KB — secondary record
Reporting date: 2026-04-09
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2026-04-09-life-biosciences-raises-80m
Claim: Life Biosciences raised $80 million to begin clinical testing of its anti-aging gene therapy, while GLP-1 drugs are projected to add $13 billion in apparel sales as Americans shrink out of their wardrobes.
Attributed sources:
- Welcome to April 9, 2026 — https://theinnermostloop.substack.com/p/welcome-to-april-9-2026
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.